Bridgette Aumand Holmes, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 8 Middle St, Keene, NH 03431 Phone: 866-476-1321 Fax: 602-352-0682 |
Marion Boardman, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 |
Georgianna Hamilton, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 8 Middle St, Keene, NH 03431 Phone: 603-352-6898 |
Ms. Autumn J Versace, CNM, APRN Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Dartmouth Hitchcock - Womens Health, Keene, NH 03431 Phone: 603-354-6534 |
Ms. Genell Lynn Mikkalson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 580 Court St, Keene, NH 03431 Phone: 603-354-5454 |
Elina Koumjian, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-6640 |
Laurie Rendall Coursin, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 |
Carlye Elizabeth Atkinson, MSN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8 Middle St, Keene, NH 03431 Phone: 603-352-6898 |
Melissa Sevoian, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 580 Court St, Keene, NH 03431 Phone: 603-354-5400 |
News Archive
Many children in the U.S. have poor diets and in fact, 1 in 3 is overweight or obese. Parents struggle to have meals together with children and provide them with nutritious foods. They often rely on convenient and processed foods.
Researchers have shown that the asthma-control benefits of bronchial thermoplasty remain for as long as 5 years following treatment.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant side effects.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
› Verified 1 days ago